Kohjin Bio Co.,Ltd. (JP:177A)
:177A
Want to see JP:177A full AI Analyst Report?
Top Page
Kohjin Bio Co.,Ltd.
(177A)
Select Model
Select Model
Rating:52Neutral
Price Target:
¥1,094.00
▼(-28.26% Downside)
Action:Reiterated
Date:05/22/26
The score is held back primarily by deteriorating recent financial performance and weak cash conversion (negative free cash flow), despite an improving and manageable leverage profile. Technicals remain soft with the stock below longer-term moving averages, and valuation looks only fair given the recent profitability and growth step-down.
Positive Factors
Improving leverage / stronger capital base
Debt-to-equity falling to ~0.37 and materially below 2022 (~1.01), combined with a meaningful equity increase, strengthens the balance sheet. This durable improvement reduces refinancing risk, raises financial flexibility for R&D or strategic moves, and supports stability through cycles.
Negative Factors
Revenue decline and margin compression
A year-over-year revenue decline (-4.7%) coupled with a sharp net margin drop to ~5.1% signals weakening demand or margin pressure. These changes materially reduce durable earnings power and could depress ROE and reinvestment capacity if the trend persists over the coming quarters.
Read all positive and negative factors
Positive Factors
Negative Factors
Improving leverage / stronger capital base
Debt-to-equity falling to ~0.37 and materially below 2022 (~1.01), combined with a meaningful equity increase, strengthens the balance sheet. This durable improvement reduces refinancing risk, raises financial flexibility for R&D or strategic moves, and supports stability through cycles.
Read all positive factors
Kohjin Bio Co.,Ltd. (177A) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥5.54B
Dividend Yield1.62%
Average Volume (3M)3.64K
Price to Earnings (P/E)22.1
Beta (1Y)0.79
Revenue Growth-5.13%
EPS Growth-68.42%
CountryJP
Employees159
SectorHealthcare
Sector Strength45
IndustryBiotechnology
Share Statistics
EPS (TTM)139.68
Shares Outstanding5,111,600
10 Day Avg. Volume4,170
30 Day Avg. Volume3,643
Financial Highlights & Ratios
PEG Ratio-0.36
Price to Book (P/B)1.04
Price to Sales (P/S)1.25
P/FCF Ratio-22.03
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)¥5.58B
Kohjin Bio Co.,Ltd. Business Overview & Revenue Model
Company Description
Kohjin Bio Co., Ltd., established in 1981 in Sakado, Japan, and known as Kohjin Co.,Ltd. until its rebranding in 1989, is a diversified life science enterprise. The company's core business involves the production and sale of various biological mat...
How the Company Makes Money
null...
Kohjin Bio Co.,Ltd. Financial Statement Overview
Summary
Income Statement
58
Neutral
Balance Sheet
71
Positive
Cash Flow
41
Neutral
| Breakdown | TTM | Mar 2026 | Mar 2026 | Mar 2025 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 5.18B | 4.94B | 5.21B | 4.77B | 4.74B | 3.95B |
| Gross Profit | 2.31B | 1.86B | 2.37B | 1.88B | 2.45B | 2.04B |
| EBITDA | 1.26B | 737.68M | 1.41B | 958.10M | 1.44B | 1.14B |
| Net Income | 714.00M | 251.02M | 794.76M | 384.00M | 829.79M | 587.67M |
Balance Sheet | ||||||
| Total Assets | 9.17B | 8.90B | 9.12B | 6.64B | 6.20B | 5.60B |
| Cash, Cash Equivalents and Short-Term Investments | 3.10B | 2.49B | 3.15B | 1.73B | 1.46B | 1.73B |
| Total Debt | 1.99B | 2.19B | 2.39B | 2.47B | 2.10B | 2.23B |
| Total Liabilities | 3.46B | 2.96B | 3.34B | 3.30B | 3.18B | 3.38B |
| Stockholders Equity | 5.71B | 5.95B | 5.78B | 3.34B | 3.02B | 2.22B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -280.78M | 28.05M | 260.88M | -99.57M | 559.44M |
| Operating Cash Flow | 0.00 | 698.51M | 915.55M | 823.68M | 461.15M | 762.98M |
| Investing Cash Flow | 0.00 | -867.67M | -1.09B | -577.35M | -575.46M | 82.78M |
| Financing Cash Flow | 0.00 | -320.76M | 1.38B | -1.35M | -172.21M | -360.17M |
Kohjin Bio Co.,Ltd. Technical Analysis
Negative
1525.00
Price Trends
1271.88
Negative
1266.37
Negative
1414.15
Negative
Market Momentum
-87.71
Positive
42.72
Neutral
28.26
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:177A, the sentiment is Negative. The current price of 1525 is above the 20-day moving average (MA) of 1227.30, above the 50-day MA of 1271.88, and above the 200-day MA of 1414.15, indicating a bearish trend. The MACD of -87.71 indicates Positive momentum. The RSI at 42.72 is Neutral, neither overbought nor oversold. The STOCH value of 28.26 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:177A.
Kohjin Bio Co.,Ltd. Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
54 Neutral | ¥137.64B | -14.34 | ― | 2.18% | -10.48% | -1022.09% | |
52 Neutral | ¥5.54B | 22.08 | ― | 1.62% | -5.13% | -68.42% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
50 Neutral | ¥24.04B | -32.72 | ― | ― | -11.11% | -187.80% | |
45 Neutral | ¥18.49B | -10.19 | ― | ― | ― | 13.18% | |
42 Neutral | ¥12.27B | -20.66 | ― | ― | -25.02% | -697.06% | |
42 Neutral | ¥9.05B | -8.83 | ― | ― | -62.06% | 7.56% |
* Healthcare Sector Average
JP:177A
Kohjin Bio Co.,Ltd.
1,083.00
-606.74
-35.91%
JP:4599
StemRIM Inc.
295.00
-16.00
-5.14%
JP:4974
Takara Bio Inc.
1,143.00
356.00
45.24%
JP:4978
ReproCELL Inc.
129.00
-57.00
-30.65%
JP:7774
Japan Tissue Engineering Co., Ltd.
592.00
-6.00
-1.00%
JP:7776
CellSeed Inc.
231.00
-285.00
-55.23%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.